Sepsis is a serious and life-threatening condition that happens when the body overreacts to an infection. Instead of fighting just the infection, the immune system becomes too aggressive and begins to damage the body’s own organs. If it gets worse, it can lead to septic shock, where blood pressure drops dangerously low and vital organs are starved of oxygen.
Every year, about 750,000 people in the United States are hospitalized with sepsis, and sadly, around 27% of them die. In even more serious cases—about 15%—patients develop septic shock, which raises the risk of death to 30–40%.
Doctors usually treat sepsis by giving patients antibiotics, fluids through an IV, and medications called vasopressors to increase blood pressure. Now, a new study published in Frontiers in Immunology offers hope that a common type of medication—statins—might also help patients survive sepsis.
Statins are best known as drugs that lower cholesterol and reduce the risk of heart attacks and strokes. They lower “bad” cholesterol (LDL) and raise “good” cholesterol (HDL). But scientists have recently discovered that statins do more than just help the heart.
They also reduce inflammation, protect blood vessels, and may even help fight infections. This has sparked interest in whether statins could help in other conditions where the body’s immune system goes into overdrive—like sepsis.
The study was led by Dr. Caifeng Li from Tianjin Medical University General Hospital in China. She and her team used data from a large hospital in Boston that keeps electronic medical records of over 265,000 patients.
They focused on adults who had sepsis and had stayed in the hospital for more than 24 hours. They compared two groups: one that received statins during their hospital stay and one that didn’t. The final analysis included over 12,000 critically ill patients—half of them had taken statins, and half had not.
Since this wasn’t a randomized trial where patients are randomly assigned to receive a drug or not, the researchers used a method called “propensity score matching.” This means they tried to match patients with similar medical conditions and histories, so the two groups would be as alike as possible—except for the statin treatment.
What they found was striking. The group that received statins had a 14.3% death rate within 28 days, compared to a 23.4% death rate in the group that did not receive statins. That’s a relative drop in the death rate of 39%.
However, there was a small downside: patients on statins needed mechanical breathing support (ventilators) and kidney support (called CRRT) for slightly longer—on average three and 26 hours more, respectively. The authors think this could be a tradeoff: patients lived longer, so they needed longer care.
Interestingly, this survival benefit from statins was seen across patients with normal, overweight, or obese body types—but not in underweight patients.
So why haven’t earlier studies shown these benefits? The authors suggest that many of those studies were too small or poorly designed. Some didn’t focus only on patients with sepsis, and others may not have looked closely enough at patient details or statin types and doses.
Dr. Li says that a large, carefully designed trial is needed to confirm these results. It would need to track not only who gets statins, but also when they start taking them, what kind they take, and for how long.
In conclusion, this large study suggests that statins might help people survive sepsis by calming the body’s dangerous immune response and protecting organs. While more research is needed to be sure, this could open up a promising new use for a medication that millions of people already take every day.
If future clinical trials confirm these findings, doctors may one day use statins not just to lower cholesterol—but also to help save lives during severe infections like sepsis.
If you care about health, please read studies that vitamin D can help reduce inflammation, and vitamin K could lower your heart disease risk by a third.
For more health information, please see recent studies about new way to halt excessive inflammation, and results showing foods that could cause inflammation.
The research findings can be found in Frontiers in Immunology.
Copyright © 2025 Knowridge Science Report. All rights reserved.
